Clustered regularly interspaced short palindromic repeats-based editing is inefficient at over two-thirds of genetic targets. A primary cause is ribonucleic acid (RNA) misfolding that can occur between the spacer and scaffold regions of the gRNA, which hinders the formation of functional Cas9 ribonucleoprotein (RNP) complexes. Here, we uncover hundreds of highly efficient gRNA variant scaffolds for Staphylococcus aureus (Sa)Cas9 utilizing an innovative binding and ligand activation driven enrichment (BLADE) methodology, which leverages asymmetrical product dissociation over rounds of evolution. SaBLADE-derived gRNA scaffolds contain 7%–42% of nucleotide variation relative to wild type. gRNA variants are able to improve gene editing efficiency at all targets tested, and they achieve their highest levels of editing improvement (>400%) at the most challenging DNA target sites for the wild-type SaCas9 gRNA. This arsenal of SaBLADE-derived gRNA variants showcases the power and flexibility of combinatorial chemistry and directed evolution to enable efficient gene editing at challenging, or previously intractable, genomic sites.
Get full access to this article
View all access options for this article.
References
1.
JinekM, ChylinskiK, FonfaraI, et al.A programmable Dual-RNA–Guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821; doi: 10.1126/science.1225829
2.
VilligerL, JoungJ, KoblanL, et al.CRISPR technologies for genome, epigenome and transcriptome editing. Nat Rev Mol Cell Biol, 2024; 25:464–487; doi: 10.1038/s41580-023-00697-6
3.
YaoR, LiuD, JiaX, et al.CRISPR-Cas9/Cas12a biotechnology and application in bacteria. Synth Syst Biotechnol, 2018; 3:135–149; doi: 10.1016/j.synbio.2018.09.004
4.
SullengerBA. RGEN Editing of RNA and DNA: the long and winding road from catalytic RNAs to CRISPR to the clinic. Cell, 2020; 181:955–960; doi: 10.1016/j.cell.2020.04.050
5.
RanFA, CongL, YanWX, et al.In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015; 520:186–191; doi: 10.1038/nature14299
6.
XiangX, CorsiGI, AnthonC, et al.Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning. Nat Commun, 2021; 12:3238; doi: 10.1038/s41467-021-23576-0
7.
YangZ-X, FuY-W, ZhaoJ-J, et al.Superior fidelity and distinct editing outcomes of SaCas9 compared with SpCas9 in genome editing. Genomics Proteomics Bioinformatics, 2023; 21:1206–1220; doi: 10.1016/j.gpb.2022.12.003
8.
ChariR, YeoNC, ChavezA, et al.sgRNA scorer 2.0: a species-independent model to predict CRISPR/Cas9 activity. ACS Synth Biol, 2017; 6:902–904; doi: 10.1021/acssynbio.6b00343
9.
Moreno-MateosMA, VejnarCE, BeaudoinJ-D, et al.CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods, 2015; 12:982–988; doi: 10.1038/nmeth.3543
10.
LabunK, MontagueTG, KrauseM, et al.CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res, 2019; 47:W171–W174; doi: 10.1093/nar/gkz365
11.
HannaRE, DoenchJG. Design and analysis of CRISPR–Cas experiments. Nat Biotechnol, 2020; 38:813–823; doi: 10.1038/s41587-020-0490-7
12.
HallB, ChoA, LimayeA, et al.Genome editing in mice using CRISPR/Cas9 technology. Curr Protoc Cell Biol, 2018; 81:e57; doi: 10.1002/cpcb.57
13.
XuK, SegalDJ, ZhangZ. Editorial: precise genome editing techniques and applications. Front Genet, 2020; 11:412; doi: 10.3389/fgene.2020.00412
14.
ThymeSB, AkhmetovaL, MontagueTG, et al.Internal guide RNA interactions interfere with Cas9-mediated cleavage. Nat Commun, 2016; 7:11750; doi: 10.1038/ncomms11750
15.
OkaforIC, HaT. Single molecule FRET analysis of CRISPR Cas9 single guide RNA folding dynamics. J Phys Chem B, 2023; 127:45–51; doi: 10.1021/acs.jpcb.2c05428
16.
XuX, DuanD, ChenS-J. CRISPR-Cas9 cleavage efficiency correlates strongly with target-sgRNA folding stability: from physical mechanism to off-target assessment. Sci Rep, 2017; 7:143; doi: 10.1038/s41598-017-00180-1
17.
RiesenbergS, HelmbrechtN, KanisP, et al.Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage. Nat Commun, 2022; 13:489; doi: 10.1038/s41467-022-28137-7
18.
BushK, CorsiGI, YanAC, et al.Utilizing directed evolution to interrogate and optimize CRISPR/Cas guide RNA scaffolds. Cell Chem Biol, 2023; 30:879–892; doi: 10.1016/j.chembiol.2023.06.007
19.
RyczekM, PlutaM, BłaszczykL, et al.Overview of methods for large-scale RNA synthesis. Appl Sci, 2022; 12:1543; doi: 10.3390/app12031543
20.
ReeseCB. Oligo- and poly-nucleotides: 50 years of chemical synthesis. Org Biomol Chem, 2005; 3:3851–3868; doi: 10.1039/b510458k
21.
FlammeM, McKenzieLK, SaracI, et al.Chemical methods for the modification of RNA. Methods, 2019; 161:64–82; doi: 10.1016/j.ymeth.2019.03.018
22.
NimjeeSM, WhiteRR, BeckerRC, et al.Aptamers as therapeutics. Annu Rev Pharmacol Toxicol, 2017; 57:61–79; doi: 10.1146/annurev-pharmtox-010716-104558
WilbanksB, PearsonK, MaherLJ. A non-rational approach to optimized targeting of CRISPR-Cas9 complexes. Cell Chem Biol, 2023; 30:855–857; doi: 10.1016/j.chembiol.2023.07.012
25.
ZhangS, ZhangQ, HouX, et al.Dynamics of staphylococcus aureus Cas9 in DNA target association and dissociation. EMBO Rep, 2020; 21:e50184; doi: 10.15252/embr.202050184
26.
NishimasuH, CongL, YanWX, et al.Crystal structure of staphylococcus aureus Cas9. Cell, 2015; 162:1113–1126; doi: 10.1016/j.cell.2015.08.007
27.
ZhangY, NishiyamaT, LiH, et al.A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation. Mol Ther Methods Clin Dev, 2021; 22:122–132; doi: 10.1016/j.omtm.2021.05.014
28.
WangY, WangB, XieH, et al.Efficient human genome editing using SaCas9 ribonucleoprotein complexes. Biotechnol J, 2019; 14:e1800689; doi: 10.1002/biot.201800689
29.
SieversF, WilmA, DineenD, et al.Fast, scalable generation of high‐quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol, 2011; 7:539; doi: 10.1038/msb.2011.75
YourikP, FuchsRT, MabuchiM, et al.Staphylococcus aureus Cas9 is a multiple-turnover enzyme. Rna, 2019; 25:35–44; doi: 10.1261/rna.067355.118
33.
LabunK, MontagueTG, GagnonJA, et al.CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res, 2016; 44:W272–W276; doi: 10.1093/nar/gkw398
34.
BrinkmanEK, ChenT, AmendolaM, et al.Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res, 2014; 42:e168; doi: 10.1093/nar/gku936
35.
ValtortaE, MartinoC, Sartore-BianchiA, et al.Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Mod Pathol, 2015; 28:1481–1491; doi: 10.1038/modpathol.2015.98
36.
LuM, WangT, HeM, et al.Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer. Oncotarget, 2017; 8:23008–23019; doi: 10.18632/oncotarget.14968
37.
YamamuraY, IwataY, FuruichiK, et al.Kif26b contributes to the progression of interstitial fibrosis via migration and myofibroblast differentiation in renal fibroblast. FASEB J, 2022; 36:e22606; doi: 10.1096/fj.202200355r
38.
LiH, ShenS, ChenX, et al.miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway. Cancer Cell Int, 2019; 19:205; doi: 10.1186/s12935-019-0923-x
39.
TibboAJ, HartleyA, VasanR, et al.MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer. Br J Cancer, 2023; 128:1991–1999; doi: 10.1038/s41416-023-02237-7
40.
CaengprasathN, TheerapanonT, PorntaveetusT, et al.MBTPS2, a membrane bound protease, underlying several distinct skin and bone disorders. J Transl Med, 2021; 19:114; doi: 10.1186/s12967-021-02779-5
41.
ClementK, ReesH, CanverMC, et al.CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol, 2019; 37:224–226; doi: 10.1038/s41587-019-0032-3
42.
WangS, MaoH, HouL, et al.Compact SchCas9 recognizes the simple NNGR PAM. Adv Sci (Weinh), 2022; 9:e2104789; doi: 10.1002/advs.202104789
43.
HuZ, ZhangC, WangS, et al.Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity. Nucleic Acids Res, 2021; 49:4008–4019; doi: 10.1093/nar/gkab148
44.
WangS, TaoC, MaoH, et al.Identification of SaCas9 orthologs containing a conserved serine residue that determines simple NNGG PAM recognition. PLoS Biol, 2022; 20:e3001897; doi: 10.1371/journal.pbio.3001897
45.
RuffoloJA, NayfachS, GallagherJ, et al.Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences. bioRxiv, 2024; 2024; doi: 10.1101/2024.04.22.590591
46.
XieH, GeX, YangF, et al.High-fidelity SaCas9 identified by directional screening in human cells. PLoS Biol, 2020; 18:e3000747; doi: 10.1371/journal.pbio.3000747
47.
TanY, ChuAHY, BaoS, et al.Rationally engineered staphylococcus aureus Cas9 nucleases with high genome-wide specificity. Proc Natl Acad Sci USA, 2019; 116:20969–20976; doi: 10.1073/pnas.1906843116
48.
YuenCTL, TheanDGL, ChanBKC, et al.High-fidelity KKH variant of Staphylococcus aureus Cas9 nucleases with improved base mismatch discrimination. Nucleic Acids Res, 2022; 50:1650–1660; doi: 10.1093/nar/gkab1291
49.
LuanB, XuG, FengM, et al.Combined computational–experimental approach to explore the molecular mechanism of SaCas9 with a broadened DNA targeting range. J Am Chem Soc, 2019; 141:6545–6552; doi: 10.1021/jacs.8b13144
SchmidtMJ, GuptaA, BednarskiC, et al.Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases. Nat Commun, 2021; 12:4219; doi: 10.1038/s41467-021-24454-5
52.
NguyenE, PoliM, DurrantMG, et al.Sequence modeling and design from molecular to genome scale with Evo. Science, 2024; 386:eado9336; doi: 10.1126/science.ado9336
WangT, LanderES, SabatiniDM. Viral packaging and cell culture for CRISPR-Based screens. Cold Spring Harb Protoc, 2016; 2016:pdb.prot090811; doi: 10.1101/pdb.prot090811
55.
EsveltKM, CarlsonJC, LiuDR. A system for the continuous directed evolution of biomolecules. Nature, 2011; 472:499–503; doi: 10.1038/nature09929
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
